EUVIMEDEUVIMED entdecken
Crossref

Ginsenoside Rk1 alleviates LPS-induced epithelial barrier injury in Caco-2 monolayers: an in vitro model of ulcerative colitis

Yan Chen, Mingfeng Liu, Minxiao Feng

Journal of Clinical Biochemistry and Nutrition · 2026

DOI: 10.3164/jcbn.26-141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Biochemistry and Nutrition, 2026. Verfasst von Yan Chen und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) manifests as damage to the intestinal epithelial barrier, disrupted oxidative homeostasis and persistent inflammatory lesions in the gut. Conventional clinical regimens often yield unsatisfactory therapeutic effects and are associated with prominent side effects. However, the protective effect of ginsenoside Rk1 against intestinal epithelial damage in UC remains unclear. This study used a lipopolysaccharide (LPS)-induced Caco-2 cell injury model to investigate the protective effect of ginsenoside Rk1. Cell viability was detected using the CCK-8 assay, and intestinal epithelial barrier integrity was evaluated using transepithelial electrical resistance (TEER). Western blot analysis and immunofluorescence staining were used to detect the expression and distribution of tight junction proteins. ELISA was used to detect inflammatory factor secretion levels, DCFH-DA fluorescence staining was used to observe cellular ROS accumulation, and changes in the expression of key proteins in the Nrf2 pathway were assessed. The results showed that LPS stimulation reduced Caco-2 cell viability and TEER values, disrupted tight junction structures and protein expression, induced inflammatory factor secretion and intensified oxidative stress-mediated cellular damage, while mildly activating a compensatory Nrf2 response. Ginsenoside Rk1, in a dose-dependent manner, improved the aforementioned damage phenotypes, effectively repaired intestinal epithelial barrier function, inhibited inflammatory and oxidative stress responses, and upregulated the expression of Nrf2, HO-1, and NQO1 proteins, thereby continuously activating the Nrf2 antioxidant pathway. In conclusion, ginsenoside Rk1 can alleviate LPS-induced intestinal epithelial oxidative stress, inflammatory responses, and barrier damage, and can activate the Nrf2 signaling pathway, demonstrating promising therapeutic potential for the prevention and treatment of ulcerative colitis.

Zitieren

APA

Chen, Y., Liu, M., & Feng, M. (2026). Ginsenoside Rk1 alleviates LPS-induced epithelial barrier injury in Caco-2 monolayers: an in vitro model of ulcerative colitis. Journal of Clinical Biochemistry and Nutrition. https://doi.org/10.3164/jcbn.26-141

Vancouver

Chen Y, Liu M, Feng M. Ginsenoside Rk1 alleviates LPS-induced epithelial barrier injury in Caco-2 monolayers: an in vitro model of ulcerative colitis. Journal of Clinical Biochemistry and Nutrition. 2026. doi:10.3164/jcbn.26-141

BibTeX
@article{Chen2026,
  author = {Chen, Yan and Liu, Mingfeng and Feng, Minxiao},
  title = {Ginsenoside Rk1 alleviates LPS-induced epithelial barrier injury in Caco-2 monolayers: an in vitro model of ulcerative colitis},
  journal = {Journal of Clinical Biochemistry and Nutrition},
  year = {2026},
  doi = {10.3164/jcbn.26-141}
}
Kostenlos starten →